Dr. Zahra Maleki

Dr. Tamara Lotan is a Professor of Pathology, Oncology and Urology at the Johns Hopkins University School of Medicine. Her area of clinical expertise is urologic pathology. Dr. Lotan received her medical degree from the University of Chicago Pritzker School of Medicine. She completed her residency in anatomic pathology at the University of Chicago Hospitals and performed a fellowship in urologic pathology at the Johns Hopkins University School of Medicine. She is a urologic pathologist and physician-scientist whose laboratory studies tissue-based predictive and prognostic biomarkers in prostate cancer. The group has a particular interest in the molecular contributors to prostate cancer health disparities. Her group also studies mTOR signaling and its role in tumorigenesis, with a focus on renal oncogenesis. Dr. Lotan is engaged in research training and is the co-PI of the OPTIC T32 in pathology, enabling pathology residents to engage in 2-3 years of laboratory research. She is currently the Deputy Director for Research Affairs in the Department of Pathology. Dr. Lotan is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, PIK3CA-Related Overgrowth Spectrum, Muscle Invasive Bladder Cancer, Prostatectomy, and Orchiectomy. Dr. Lotan is board certified in American Board Of Pathology. Dr. Lotan is currently accepting new patients.

Sudhir Sekhsaria is an Allergy and Immunologist practicing medicine in Baltimore, Maryland. Dr. Sekhsaria is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Allergic Rhinitis, Sinusitis, Grass Allergy, and Hives. Dr. Sekhsaria is board certified in American Board Of Allergy And Immunology - Allergy And Immunology, 1993. Dr. Sekhsaria is currently accepting new patients.

Dr. Charles Eberhart is a professor of pathology, oncology, and ophthalmology, at the Johns Hopkins University School of Medicine. His research primarily focuses on molecular genetics and treatment of medulloblastoma, gliomas, retinoblastoma, uveal melanoma and other tumors of the brain and eye. Dr. Eberhart serves as the director of the Divisions of Neuropathology and Ophthalmic Pathology. Major research areas in his laboratory include targeting functionally important signaling pathways in tumors, identifying the genetic drivers of rare neoplasms in the brain and eye, and building new models of tumors. He received his undergraduate degree in biochemistry from the University of Texas at Austin and earned his M.D./Ph.D. from UT Southwestern Medical School. He also was a fellow at the Max Planck Institute for one year. Dr. Eberhart completed both a residency in anatomic pathology and a fellowship in neuropathology at The Johns Hopkins Hospital, then joined the Johns Hopkins faculty in 2001. Dr. Eberhart has been recognized with the Howard Hughes Medical Institute Postdoctoral Research Fellowship for Physicians, and career development awards from the Burroughs Wellcome Fund and the National Institutes of Health. He has published more than 350 original research articles, numerous case reports, reviews and book chapters, and is on the editorial board of the Journal of Neuro-Oncology, Brain Pathology and the Journal of Neuropathology and Experimental Neurology. Dr. Eberhart is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pediatric Low-Grade Glioma (pLGG), Neurofibromatosis, Conjunctivitis (Pink Eye), IgG4-Related Disease, and Vitrectomy. Dr. Eberhart is board certified in American Board Of Pathology. Dr. Eberhart is currently accepting new patients.